|
Elezanumab
|
DB15240 |
[Elezanumab is under investigation in clinical trial NCT03737812 (A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis).] |
|
2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a
|
DB15243 |
[2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a is under investigation in clinical trial NCT01668823 (Photodynamic Therapy in Treating Patients With Lung Cancer).] |
|
MK-0533
|
DB15242 |
[MK-0533 is under investigation in clinical trial NCT00543959 (Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)).] |
|
4,6-Dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino}hexopyranose
|
DB03269 |
|
|
2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID
|
DB04598 |
|
|
1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine
|
DB03267 |
|
|
RU82197
|
DB03268 |
|
|
Aniracetam
|
DB04599 |
[Compound with anti-depressive properties used as a mental performance enhancer.] |
|
4-O-{4,6-O-[(1S)-1-Carboxyethylidene]-β-D-mannopyranosyl}-D-glucopyranuronic acid
|
DB04596 |
|
|
Glutaral
|
DB03266 |
[One of the protein CROSS-LINKING REAGENTS that is used as a disinfectant for sterilization of heat-sensitive equipment and as a laboratory reagent, especially as a fixative.] |
|
[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]
|
DB04597 |
|
|
2',5'-Dideoxyuridine
|
DB03274 |
|
|
Cysteinamide
|
DB03275 |
|
|
4-Bromo-3-(5'-Carboxy-4'-Chloro-2'-Fluorophenyl)-1-Methyl-5-Trifluoromethyl-Pyrazol
|
DB03272 |
|
|
3'-Oxo-Adenosine
|
DB03273 |
|
|
2,6-Difluorobenzenesulfonamide
|
DB03270 |
|
|
VB-201
|
DB15259 |
[VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).] |
|
Reldesemtiv
|
DB15256 |
[Reldesemtiv is under investigation in clinical trial NCT03160898 (A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)).] |
|
Imlifidase
|
DB15258 |
[Imlifidase is under investigation in clinical trial NCT02854059 (IdeS in Asymptomatic Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients).] |
|
Milademetan
|
DB15257 |
[Milademetan is under investigation in clinical trial NCT02319369 (Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)).] |
